Access to medicines: Difference between revisions
Expand source-linked scientific reference and navigation |
Add complete multilingual reference and language navigation |
||
| Line 1: | Line 1: | ||
<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Access to medicines|English]] · [[Access to medicines/uk|Українська]] · [[Access to medicines/es|Español]] · [[Access to medicines/fr|Français]] · [[Access to medicines/de|Deutsch]] · [[Access to medicines/pt|Português]]</div> | |||
Access to medicines is a distinct question from whether a medicine exists or has a recognized pharmacological action. Research can examine the legal, organizational and product-related conditions under which people can obtain appropriate care. | Access to medicines is a distinct question from whether a medicine exists or has a recognized pharmacological action. Research can examine the legal, organizational and product-related conditions under which people can obtain appropriate care. | ||
Latest revision as of 00:52, 12 November 2026
Access to medicines is a distinct question from whether a medicine exists or has a recognized pharmacological action. Research can examine the legal, organizational and product-related conditions under which people can obtain appropriate care.
Andrii Gudzenko's 2021 study examines availability for medicines identified by three international nonproprietary names in the context of mental-health care for affected populations. It links availability analysis with clinical-pharmacological and legal classifications. Its comparative conclusion belongs to that study and period; it should not be converted into a universal ranking of antidepressants or a recommendation for individual treatment.
For a scientific wiki, the study is useful as an example of the relationship between pharmaceutical provision, patient groups and regulatory categories. Appropriate prescribing remains an individual clinical decision. Related topics: socially oriented pharmaceutical care, pharmaceutical law, pharmacoeconomic analysis and medicine classification.
Source
Gudzenko, A. (2021). Determining The Availability of Antidepressants for The Pharmacotherapy of Mental Disorders Among Victims (Experimental Study). SSP Modern Pharmacy and Medicine, 1(2).
See also: Terms and concepts index · Journal research map · History and research foundations.